News

The new service will help its clients, entering for formulation development, to enhance oral bioavailability of their BCS II and IV compounds. Several pharmaceutical companies face solubility challenges

Trastuzumab Emtansine is designed to treat people with HER2-positive, unresectable locally advanced or metastatic breast cancer who have received prior treatment with Herceptin and a taxane chemotherapy. European

Acetadote is a drug used to minimize liver damage from acetaminophen overdoses in hospital emergency rooms. The new patent that covers the use of 200mg/ml Acetadote formulation provides

The new App, with one button click, allows researchers to identify DAB-labeled tissue, measure the integrated optical density of the stained area, output an annotated image and export

Around 1,000 patients from six countries will participate in the five-year Phase III trial. The pharmaceutical company will leverage the technology platform to accomplish the reduction in time

Under the agreement, Chiesi will receive an initial payment of $1m, a milestone payment of $2.5 m upon first commercial sale of the product and royalties based on

As a result of the modification, the Collaboration Agreement will terminate no later than 24 April 2013 and the companies will continue to perform all the obligations as

The time to beginning of symptom relief was the primary endpoint of the study that assessed the safety and efficacy profile of Ruconest (recombinant human C1 esterase inhibitor)

LCGC president, CSO and founder Melvin Reichman will begin a new global health and development research project, titled "A Totally New Approach to Discover Malaria Combination Drugs.” Reichman